A Graphene Platform for Sensitive Electrochemical Immunoassay of Carcinoembryoninc Antigen Based on Gold-Nanoflower Biolabels

A new graphene immunosensing platform based on a new electrochemical immunosensor was designed for sensitive screening of carcinoembryoninc antigen (CEA) as a model biomarker in clinical immunoassay. Gold nanoflowers and single‐stranded DNA (ssDNA) molecules were initially assembled onto the surface...

Full description

Saved in:
Bibliographic Details
Published in:Electroanalysis (New York, N.Y.) N.Y.), 2011-04, Vol.23 (4), p.832-841
Main Authors: Su, Biling, Tang, Juan, Yang, Huanghao, Chen, Guonan, Huang, Jianxin, Tang, Dianping
Format: Article
Language:English
Subjects:
Carcinoembryoninc antigen
Electroanalysis
Gold
Gold nanoflowers
Graphene
Immunoassay
Immunosensor
Immunosensors
Nanocomposites
Nanomaterials
Nanostructure
Platforms
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A new graphene immunosensing platform based on a new electrochemical immunosensor was designed for sensitive screening of carcinoembryoninc antigen (CEA) as a model biomarker in clinical immunoassay. Gold nanoflowers and single‐stranded DNA (ssDNA) molecules were initially assembled onto the surface of graphene for the fabrication of the electrochemical immunosensor using layer‐by‐layer strategy, and then a sandwich‐type immunoassay format was developed for CEA detection based on gold nanoflower‐labeled signal antibodies. Graphene nanosheets with high conductivity and biocompatibility could greatly enhance the bound force with ssDNA, and improve the analytical properties of the immunosensor. Gold nanoflowers with electrochemical activity provide a large surface area for the label of biomolecules. The graphene platform displayed a good electrochemical behaviour toward the detection of CEA. Under optimal conditions, the electrochemical immunosensor exhibited a wide dynamic range of 0.05 to 45 ng mL−1 with a relatively low detection limit of 0.01 ng mL−1 CEA at signal‐to‐noise ratio of 3. Intra‐ and interassay coefficients of variation were below 12 %. The feasibility of the electrochemical immunosensor was evaluated for real‐life clinical specimens, and no significant differences at the 95 % confidence level were encountered between the immunosensor and commercially available Roche Elecsys 2010 Electrochemiluminescent Automatic Analyzer. In addition, the analytical properties of the immunosensor were comparatively favourable with those of other electrochemical immunosensors.
ISSN:1040-0397
1521-4109
1521-4109
DOI:10.1002/elan.201000635